ALS2CR8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.96269692007445E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.66880020492056E-10 |
Normal-vs-Stage2 |
1.538520E-03 |
Normal-vs-Stage3 |
1.33226762955019E-15 |
Normal-vs-Stage4 |
3.66373598126302E-15 |
Stage1-vs-Stage2 |
3.995200E-01 |
Stage1-vs-Stage3 |
9.364600E-04 |
Stage1-vs-Stage4 |
6.45870000000048E-05 |
Stage2-vs-Stage3 |
1.149900E-02 |
Stage2-vs-Stage4 |
3.395000E-03 |
Stage3-vs-Stage4 |
4.536200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.66022751102446E-12 |
Normal-vs-AfricanAmerican |
6.85619999996057E-07 |
Normal-vs-Asian |
2.720600E-01 |
Caucasian-vs-AfricanAmerican |
6.281000E-01 |
Caucasian-vs-Asian |
1.034010E-01 |
AfricanAmerican-vs-Asian |
1.844640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.99680288865056E-15 |
Normal-vs-Female |
6.46590003761105E-09 |
Male-vs-Female |
1.501530E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.08970000023412E-07 |
Normal-vs-Age(41-60Yrs) |
1.17309995051329E-09 |
Normal-vs-Age(61-80Yrs) |
1.64313007644523E-12 |
Normal-vs-Age(81-100Yrs) |
1.970320E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.308300E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.296000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.608600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.070500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.855800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.565000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.780750E-01 |
Normal-vs-Grade 2 |
2.33199999977174E-07 |
Normal-vs-Grade 3 |
1.62481139653892E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
2.403600E-01 |
Grade 1-vs-Grade 3 |
7.320600E-03 |
Grade 1-vs-Grade 4 |
5.216400E-03 |
Grade 2-vs-Grade 3 |
3.283700E-03 |
Grade 2-vs-Grade 4 |
1.14989995303461E-09 |
Grade 3-vs-Grade 4 |
2.558700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62818999999148E-05 |
Normal-vs-ccB subtype |
1.62470037423645E-12 |
ccA subtype-vs-ccB subtype |
1.88820000002199E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.56260054579627E-10 |
Normal-vs-N1 |
2.06229999966112E-07 |
N0-vs-N1 |
4.538000E-02 |
|
|